Evidence map›Paper›PMID 20671195›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2010

Intestine-specific transcription factor Cdx2 induces E-cadherin function by enhancing the trafficking of E-cadherin to the cell membrane.

Shinsuke Funakoshi, Jianping Kong, Mary Ann Crissey, Long Dang, Duyen Dang, John P Lynch

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Cdx1 and Cdx2 function as tumor suppressors.The Journal of biological chemistry · 2014
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shinsuke FunakoshiDivision of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jianping Kong
Mary Ann Crissey
Long Dang
Duyen Dang
John P Lynch
University of Pennsylvania · USUniversity of Florida · USUniversity of Michigan–Ann Arbor · US

Funding

TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
HPV AND CELL CYCLE DYSREGULATION IN ORAL CANCERP01DE012467 · NIDCR · MASSACHUSETTS GENERAL HOSPITAL · PI WONG, DAVID T · 1998 to 2002
$3.2M
Cdx2 modulates beta-catenin activity in intestinal cellsR01DK068366 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LYNCH, JOHN P. · 2006 to 2010
$1.4M
NIDCR NIH HHS P01 DE-12467NIDDK NIH HHS DK-068366NIDDK NIH HHS P30-DK-50306NIDDK NIH HHS R01 DK068366
6 · The paper itself

Abstract

Cdx2 is an intestine-specific transcription factor required for normal intestinal epithelium development. Cdx2 regulates the expression of intestine-specific genes and induces cell adhesion and columnar morphogenesis. Cdx2 also has tumor-suppressor properties, including the reduction of colon cancer cell proliferation and cell invasion, the latter due to its effects on cell adhesion. E-cadherin is a cell adhesion protein required for adherens junction formation and the establishment of intestinal cell polarity. The objective of this study was to elucidate the mechanism by which Cdx2 regulates E-cadherin function. Two colon cancer cell lines were identified in which Cdx2 expression was associated with increased cell-cell adhesion and diminished cell migration. In both cell lines, Cdx2 did not directly alter E-cadherin levels but increased its trafficking to the cell membrane compartment. Cdx2 enhanced this trafficking by altering receptor tyrosine kinase (RTK) activity. Cdx2 expression diminished phosphorylated Abl and phosphorylated Rac levels, which are downstream effectors of RTKs. Specific chemical inhibition or short interfering RNA (shRNA) knockdown of c-Abl kinase phenocopied Cdx2's cell-cell adhesion effects. In Colo 205 cells, Cdx2 reduced PDGF receptor and IGF-I receptor activation. This was mediated by caveolin-1, which was induced by Cdx2. Targeted shRNA knockdown of caveolin-1 restored PDGF receptor and reversed E-cadherin membrane trafficking, despite Cdx2 expression. We conclude that Cdx2 regulates E-cadherin function indirectly by disrupting RTK activity and enhancing E-cadherin trafficking to the cell membrane compartment. This novel mechanism advances Cdx2's prodifferentiation and antitumor properties and suggests that Cdx2 may broadly regulate RTK activity in normal intestinal epithelium by modulating membrane trafficking of proteins.

Indexed as

Analysis of VarianceBlotting, WesternCadherinsCDX2 Transcription FactorCell AdhesionCell Line, TumorCell MembraneCell MovementCells, CulturedColonFluorescent Antibody TechniqueHomeodomain ProteinsHumansPhosphorylationProtein TransportReceptor, IGF Type 1CadherinsCDX2 protein, humanCDX2 Transcription FactorHomeodomain ProteinsReceptor, IGF Type 1Receptors, Platelet-Derived Growth Factor

Identifiers

PMID20671195
PMCPMC2993167
OpenAlexW1969384824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.